Urticaria/hives; Burning sensation; Face swelling; crawling skin; she experienced a face sunburn; bottom lip swelling; sweats; Rash/rash went from her neck to up side of face and back; Itchy; got almost like a sunburn, It's on my face, like my cheeks and nose; extremely tired and slept; Night sweats; Palpitations; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (got almost like a sunburn, It's on my face, like my cheeks and nose), NIGHT SWEATS (Night sweats), PALPITATIONS (Palpitations), URTICARIA (Urticaria/hives) and BURNING SENSATION (Burning sensation) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cesarean section and Gallbladder removal. Concurrent medical conditions included Sulfonamide allergy (Allergy to Sulphur drugs.) and Blood pressure high (Controlled with medication.). Concomitant products included IRBESARTAN for Blood pressure high, VITAMIN B12 NOS and CENTRUM SILVER FORTE for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced NIGHT SWEATS (Night sweats) and PALPITATIONS (Palpitations). On 27-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ERYTHEMA (got almost like a sunburn, It's on my face, like my cheeks and nose) and FATIGUE (extremely tired and slept). On an unknown date, the patient experienced URTICARIA (Urticaria/hives), BURNING SENSATION (Burning sensation), SWELLING FACE (Face swelling), FORMICATION (crawling skin), SUNBURN (she experienced a face sunburn), LIP SWELLING (bottom lip swelling), HYPERHIDROSIS (sweats), RASH (Rash/rash went from her neck to up side of face and back) and PRURITUS (Itchy). The patient was treated with PREDNISONE ACETATE (PREDNISONE [PREDNISONE ACETATE]) ongoing from 17-Feb-2021 for Adverse event, at a dose of 4 mg; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing from 02-Feb-2021 for Adverse event, at a dose of 2 dosage form; ASPIRIN [ACETYLSALICYLIC ACID] ongoing from 26-Feb-2021 for Adverse event, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) ongoing from 26-Feb-2021 for Adverse event, at a dose of 1 dosage form and PREDNISONE for Urticaria, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (got almost like a sunburn, It's on my face, like my cheeks and nose), NIGHT SWEATS (Night sweats), PALPITATIONS (Palpitations), URTICARIA (Urticaria/hives), BURNING SENSATION (Burning sensation), SWELLING FACE (Face swelling), FORMICATION (crawling skin), SUNBURN (she experienced a face sunburn), LIP SWELLING (bottom lip swelling), HYPERHIDROSIS (sweats), RASH (Rash/rash went from her neck to up side of face and back), FATIGUE (extremely tired and slept) and PRURITUS (Itchy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Urine analysis: abnormal (abnormal) high white blood cell count.         The patient reported a return of her hives within 2 to 3 days after completing a 6 day Prednisone taper.   This case was linked to MOD-2021-029577 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant follow up